August Verbruggen
About
In The Last Decade
August Verbruggen
11 papers receiving 49 citations
Peers
Comparison fields: 5 of 26
- Rheumatology 34
- Surgery 18
- Hematology 16
- Molecular Biology 10
- Orthopedics and Sports Medicine 8
Countries citing papers authored by August Verbruggen
This map shows the geographic impact of August Verbruggen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by August Verbruggen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites August Verbruggen more than expected).
Fields of papers citing papers by August Verbruggen
This network shows the impact of papers produced by August Verbruggen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by August Verbruggen. The network helps show where August Verbruggen may publish in the future.
Co-authorship network of co-authors of August Verbruggen
This figure shows the co-authorship network connecting the top 25 collaborators of August Verbruggen. A scholar is included among the top collaborators of August Verbruggen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with August Verbruggen. August Verbruggen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Baseline scintigraphic detection of TNFa as a predictor of therapy response after treatment with certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients | 1 |
| 3 | Scintigraphic detection of TNF alpha with a radiolabeled anti-TNF alpha in patients with active peripheral spondyloarthritis and rheumatoid arthritis | 2 |
| 4 | 99mTc labelled S-HYNIC certolizumab pegol for selecting patients for anti-TNF alpha treatment: a biodistribution and dosimetric study | 1 |
| 5 | 19 | |
| 6 | Biomechanical stretch is a key initiating event in the development of enthesitis in murine spondyloarthritis | 1 |
| 7 | Xylosan polysulphate as a symptom modifying osteoarthritis drug in patients with finger joint arthritis | 1 |
| 8 | A prospective study of alginate seeded with mature allogenic human chondrocytes in the treatment of articular cartilage defects | 3 |
| 9 | Chondrocyte Growth in Porous Spider Silk 3D-Scaffolds | 4 |
| 10 | T cell cytokines in gut mucosa of patients with spondyloarthropathy reflect immune alterations in Crohn's disease | 3 |
| 11 | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.